In this retrospective study, 138 cases of primary lung adenocarcinoma (LUAD) with clinical annotated status were analyzed for their immune gene expression profile as detected by NanoString technology along with protein expression levels of PD-L1, CD4, and CD8 in tumor cells and associated tumor-infiltrating immune cells, respectively. This evidence concerns the gene CD4 and neoplasm.